Ipratropium bromide delivered orally by metered dose inhaler does not decrease salivary flow in normal subjects.
- 1 September 1992
- journal article
- clinical trial
- Published by Wiley
- Vol. 34 (3) , 266-268
- https://doi.org/10.1111/j.1365-2125.1992.tb04135.x
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Vasomotor rhinitis and the systemic absorption of ipratropium bromide.1990
- EFFICACY OF BENZTROPINE THERAPY FOR DROOLINGDevelopmental Medicine and Child Neurology, 1989
- Transdermal scopolamine in droolingJournal of Intellectual Disability Research, 1988
- Ordinary and high-dose ipratropium in perennial nonallergic rhinitisJournal of Allergy and Clinical Immunology, 1987
- The absence of systemic side-effects from high doses of ipratropium in the nose.1983
- Chemistry and pharmacokinetics of ipratropium bromide.1979
- The chemistry of new derivatives of tropane alkaloids and the pharmacokinetics of a new quarternary compound.1975